Gladius Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,500
| Closed | -$25.8K | – | 219 |
|
|
2024
Q3 | $25.8K | Sell |
5,500
-833
| -13% | -$3.91K | ﹤0.01% | 218 |
|
|
2024
Q2 | $35.8K | Sell |
6,333
-3,179
| -33% | -$18K | ﹤0.01% | 140 |
|
|
2024
Q1 | $39.1K | Buy |
9,512
+2,355
| +33% | +$9.68K | 0.01% | 167 |
|
|
2023
Q4 | $30.2K | Buy |
7,157
+2,083
| +41% | +$8.79K | ﹤0.01% | 203 |
|
|
2023
Q3 | $21.9K | Buy |
5,074
+114
| +2% | +$492 | ﹤0.01% | 245 |
|
|
2023
Q2 | $32.7K | Buy |
4,960
+253
| +5% | +$1.67K | ﹤0.01% | 156 |
|
|
2023
Q1 | $32K | Buy |
4,707
+1,229
| +35% | +$8.35K | ﹤0.01% | 198 |
|
|
2022
Q4 | $25.7K | Buy |
3,478
+49
| +1% | +$362 | ﹤0.01% | 253 |
|
|
2022
Q3 | $34K | Sell |
3,429
-608
| -15% | -$6.03K | ﹤0.01% | 218 |
|
|
2022
Q2 | $45K | Buy |
+4,037
| New | +$45K | ﹤0.01% | 197 |
|